CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinoma
Stephen Muth, May Tun Saung, Alex B. Blair, MacKenzie Henderson, Dwayne L. Thomas, Lei Zheng
Topics & Concepts
CD137Cancer researchImmunotherapyCD8EffectorCytotoxic T cellT cellPancreatic cancerCancer immunotherapyImmunologyMedicineBiologyImmune systemCancerInternal medicineIn vitroBiochemistryCancer Immunotherapy and BiomarkersCAR-T cell therapy researchPancreatic and Hepatic Oncology Research